Successful and Safe Treatment of Chronic Spontaneous Urticaria with Omalizumab in a Woman during Two Consecutive Pregnancies

Figure 1

Urticaria activity from 2009 to 2015. Note: as no validated scoring system of urticaria activity was used during the course of treatment, the urticaria activity was scored on the basis of the severity of symptoms of remission or relapse described in the medical journal of the patient. The activity (-axis) is scored from 0 (no urticarial activity) to 10 (most severe urticarial activity) depending on the description in the patient record. -axis denotes course of treatment with graphical representation of periods with medical treatment.